Wang et al 2018 – Building Synergy between Regulatory and HTA Agencies

Objectives: To evaluate the current practice of companies and agencies to assess the changes made in aligning regulatory and health technology assessment (HTA) stakeholders; to identify areas of commonality [...]

CIRS RD Briefing 64: Review of HTA outcomes and timelines 2014-2015

Timely recommendation for drug reimbursement by health technology assessment (HTA) agencies is critical to ensure patient access to medicines of therapeutic value. As part of an ongoing study to [...]

2021-01-22T14:34:35+00:00October 1st, 2017|Tags: |

CIRS RD Briefing 63: HTA process maps

This R&D Briefing summarises the background and methodology of process mapping with examples to demonstrate the steps involved in regulatory, HTA and coverage processes for new medicines. Process maps [...]

2021-10-14T13:31:26+00:00August 31st, 2017|Tags: |